Clavis Technology (Norway)

Antiproliferative activity and mechanism of action of fatty acid derivatives of arabinofuranosylcytosine in leukemia and solid tumor cell lines

Andries M. Bergman, C.M. Kuiper, Daphne Voorn et al. · Biochemical Pharmacology · 2003 · 85 citations · Full text

Life Sciences, Biochemistry, Medicinal Chemistry +12

The Role of Human Equilibrative Nucleoside Transporter 1 on the Cellular Transport of the DNA Methyltransferase Inhibitors 5-Azacytidine and CP-4200 in Human Leukemia Cells

Johanna Hummel-Eisenbeiss, Antje Hascher, Petter‐Arnt Hals et al. · Molecular Pharmacology · 2013 · 48 citations

Medicine, Oncology, Pharmacology +14

Antiproliferative Activity and Mechanism of Action of Fatty Acid Derivatives of Gemcitabine in Leukemia and Solid Tumor Cell Lines and in Human Xenografts

Andries M. Bergman, Catharina M. Kuiper, Paul Noordhuis et al. · Nucleosides Nucleotides & Nucleic Acids · 2004 · 34 citations · Full text

Life Sciences, Oncology, Pharmacology +14

Antiproliferative Activity and Mechanism of Action of Fatty Acid Derivatives of Arabinosylcytosine (ara‐C) in Leukemia and Solid Tumor Cell Lines

Andries M. Bergman, C.M. Kuiper, Finn Myhren et al. · Nucleosides Nucleotides & Nucleic Acids · 2004 · 30 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +15

Induction of Resistance to the Lipophilic Cytarabine Prodrug Elacytarabine (CP-4055) in CEM Leukemic Cells

A. D. Adema, Nienke Losekoot, Kees Smid et al. · Nucleosides Nucleotides & Nucleic Acids · 2010 · 18 citations

Medicine, Oncology, Pharmacology +14